Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (7 items missing)
No data available for the selected time periods
in million USD H1 '15H2 '15H1 '16
License revenue
0
n/a
1
Research and development
5
n/a
9
General and administrative
4
n/a
2
Total operating expenses
9
n/a
11
Loss from operations
-9
n/a
-11
Other income (expense)
0
n/a
0
Net loss
-9
n/a
-11
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (27 items missing)
No data available for the selected time periods
in million USD H1 '15H2 '15H1 '16
Assets
Cash and cash equivalents
n/a
20
55
Prepaid expenses
n/a
0
1
Other current assets
n/a
0
0
Total current assets
n/a
20
56
Property and equipment, net
n/a
0
0
Deferred offering costs
n/a
0
0
Other assets
n/a
0
0
Total assets
n/a
21
56
Liabilities and owners' equity
Accounts payable
n/a
1 1469000
2 2366000
Accrued liabilities
n/a
2 1985000
2 1940000
Current portion of long-term debt
n/a
2 1733000
2 2400000
Current portion of deferred revenue
n/a
0 0
0 20000
Current portion of deferred rent
n/a
0 9000
0 7000
Total current liabilities
n/a
5 5196000
7 6733000
Deferred revenue
n/a
1 700000
0 170000
Deferred rent
n/a
0 3000
0 0
Long-term debt
n/a
4 4243000
3 3286000
Other non-current liabilities
n/a
0 258000
0 79000
Total liabilities
n/a
10 10400000
10 10268000
Commitments and contingencies
n/a
0 0
0 0
Total convertible preferred stock
n/a
47 47314000
0 0
Preferred stock, $0.001 par value; 10,000,000 shares authorized and no shares issued at June 30, 2016; no shares authorized or issued at December 31, 2015
n/a
0 0
0 0
Common stock, $0.001 par value; 100,000,000 shares authorized and 19,594,302 shares issued and outstanding at June 30, 2016; 40,000,000 shares authorized and 2,659,262 shares issue
n/a
0 3000
0 20000
Additional paid-in capital
n/a
3 2701000
96 95790000
Accumulated deficit
n/a
-39 -39363000
-50 -49914000
Total stockholders’ equity (deficit)
n/a
-37 -36659000
46 45896000
Total liabilities, convertible preferred stock and stockholders’ equity (deficit)
n/a
21 21055000
56 56164000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (27 items missing)
No data available for the selected time periods
in million USD H1 '15H2 '15H1 '16
Net loss
-9
n/a
-11
Depreciation
0
n/a
0
Share-based compensation expense
0
n/a
0
Non-cash interest expense
0
n/a
0
Accretion of debt discount
0
n/a
0
Change in fair value of warrant liability
0
n/a
0
Loss on sale of fixed assets
0
n/a
0
Prepaid expenses and other current assets
0
n/a
-1
Other assets
2
n/a
1
Accounts payable and accrued liabilities
0
n/a
1
Deferred revenue
1
n/a
-1
Deferred rent
0
n/a
0
Net cash used in operating activities
-7
n/a
-10
Acquisition of property and equipment
0
n/a
0
Proceeds from the sale of fixed assets
0
n/a
0
Net cash used in investing activities
0
n/a
0
Proceeds from initial public offering, net of issuance costs
0
n/a
45
Proceeds from issuance of long-term debt
6
n/a
0
Principal payments made on long-term debt
0
n/a
0
Proceeds from exercise of stock options
0
n/a
0
Net cash provided by financing activities
6
n/a
45
Net increase (decrease) in cash and cash equivalents
-1
n/a
35
Conversion of convertible preferred stock to common stock
0
n/a
48
Reclassification of deferred initial public offering costs
0
n/a
2
Issuance of warrant to purchase Series B preferred stock
0
n/a
0
Accretion of redeemable convertible preferred stock to redemption value
0
n/a
1
Unpaid initial public offering costs in accounts payable and accrued expenses
0
n/a
0
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,